Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
Superinvestors holding AKRO, Q3 2025
No superinvestor reported holding AKRO in Q3 2025.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of AKRO each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2023
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−7.6%)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−6.3%)
Q4 2022
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−53.6%)
Q3 2022
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−50.0%)
Q2 2022
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (0.0%)
Q4 2021
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−11.8%)
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−7.0%)